相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advances in the treatment of HIV/HCV coinfection in adults
Stefan Schlabe et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
The role of nanomaterials in cell delivery systems
Ali Golchin et al.
MEDICAL MOLECULAR MORPHOLOGY (2018)
Tisagenlecleucel - the first approved CAR-T-cell therapy: implications for payers and policy makers
Vinay Prasad
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Implementing a Program of Talimogene laherparepvec
Frances Collichio et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts
Ping-Pin Zheng et al.
DRUG DISCOVERY TODAY (2018)
CAR-T in the clinic: drive with care
Rafael J. Yanez-Munoz et al.
GENE THERAPY (2018)
NK cell therapy for hematologic malignancies
Rohtesh S. Mehta et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)
The exosomes released from different cell types and their effects in wound healing
Ali Golchin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB-IVM1c melanoma
Jason Chesney et al.
MELANOMA RESEARCH (2018)
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy - Moving Target for Industry?
Paula Salmikangas et al.
PHARMACEUTICAL RESEARCH (2018)
Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives
Marina Franca Dias et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Factors Influencing the Umbilical Cord Blood Stem Cell Industry: An Evolving Treatment Landscape
Carla Dessels et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
Industrializing Autologous Adoptive Immunotherapies: Manufacturing Advances and Challenges
Rohin K. Iyer et al.
FRONTIERS IN MEDICINE (2018)
Chimeric antigen receptor T cells, a savior with a high price
Gilberto de Lima Lopes et al.
CHINESE CLINICAL ONCOLOGY (2018)
Topical Review: MACI as an Emerging Technology for the Treatment of Talar Osteochondral Lesions
Travis J. Dekker et al.
FOOT & ANKLE INTERNATIONAL (2017)
Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action
Tae-Hoon Shin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
FDA Approval of Tisagenlecleucel Promise and Complexities of a $475 000 Cancer Drug
Peter B. Bach et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Stephen Russell et al.
LANCET (2017)
Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?
Santiago Roura et al.
STEM CELL RESEARCH & THERAPY (2017)
Stem Cell Therapy for Congenital Heart Disease A Systematic Review
Diamantis I. Tsilimigras et al.
CIRCULATION (2017)
A Review of Chronic Granulomatous Disease
Danielle E. Arnold et al.
ADVANCES IN THERAPY (2017)
Hematopoietic cell transplantation for aplastic anemia
Rajat Kumar et al.
CURRENT OPINION IN HEMATOLOGY (2017)
Scientific considerations for the regulatory evaluation of cell therapy products
John Petricciani et al.
BIOLOGICALS (2017)
Tisagenlecleucel, an approved anti-CD19 chimeric antigen receptor T-cell therapy for the treatment of leukemia
Y. Liu et al.
DRUGS OF TODAY (2017)
Cell therapy for lung disease
Sabine Geiger et al.
EUROPEAN RESPIRATORY REVIEW (2017)
Cellular Therapies for Muscular Dystrophies: Frustrations and Clinical Successes
Elisa Negroni et al.
HUMAN GENE THERAPY (2016)
Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
Alimuddin Zumla et al.
LANCET INFECTIOUS DISEASES (2016)
Genome-editing Technologies for Gene and Cell Therapy
Morgan L. Maeder et al.
MOLECULAR THERAPY (2016)
Andexanet alfa for the reversal of Factor Xa inhibitor related anticoagulation
Kamrouz Ghadimi et al.
EXPERT REVIEW OF HEMATOLOGY (2016)
Sipuleucel-T (Provenge®)-Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention
Szymon Jaroslawski et al.
BIODRUGS (2015)
Cord Blood Banking in the Arab World: Current Status and Future Developments
Monica M. Matsumoto et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
A Need for Renewed and Cohesive US Policy on Cord Blood Banking
Monica M. Matsumoto et al.
STEM CELL REVIEWS AND REPORTS (2015)
The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy
Jun Zhang et al.
STEM CELL RESEARCH & THERAPY (2015)
A Need for Renewed and Cohesive US Policy on Cord Blood Banking
Monica M. Matsumoto et al.
STEM CELL REVIEWS AND REPORTS (2015)
The Role of Stem Cells in Aesthetic Surgery: Fact or Fiction?
Adrian McArdle et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
New and Emerging Techniques in Cartilage Repair: Matrix-Induced Autologous Chondrocyte Implantation
Brad S. Dunkin et al.
OPERATIVE TECHNIQUES IN SPORTS MEDICINE (2013)
Autologous Fibroblast Culture in the Repair of Aging Skin
Lilian Pinero Eca et al.
DERMATOLOGIC SURGERY (2012)
A Multicenter, Double-Blind, Placebo-Controlled Trial of Autologous Fibroblast Therapy for the Treatment of Nasolabial Fold Wrinkles
Stacy R. Smith et al.
DERMATOLOGIC SURGERY (2012)
Gintuit cell therapy approval signals shift at US regulator
Charles Schmidt
NATURE BIOTECHNOLOGY (2012)
Hemacord approval may foreshadow regulatory creep for HSC therapies
Malorye Allison
NATURE BIOTECHNOLOGY (2012)
Stem cell therapy in neurodegenerative diseases From principles to practices
Rajalingham Sakthiswary et al.
NEURAL REGENERATION RESEARCH (2012)
Remodeling of Articular Cartilage and Subchondral Bone After Bone Grafting and Matrix-Associated Autologous Chondrocyte Implantation for Osteochondritis Dissecans of the Knee
Bjoern Gunnar Ochs et al.
AMERICAN JOURNAL OF SPORTS MEDICINE (2011)
Stem Cell Technology for Neurodegenerative Diseases
J. Simon Lunn et al.
ANNALS OF NEUROLOGY (2011)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
FDA approves first cell therapy for wrinkle-free visage
Charles Schmidt
NATURE BIOTECHNOLOGY (2011)
Recent advances in the therapy of castration-resistant prostate cancer: The price of progress
Dhwanishiva Vasani et al.
MATURITAS (2011)
A Pilot Study to Evaluate a Tissue-Engineered Bilayered Cell Therapy as an Alternative to Tissue From the Palate
Michael K. McGuire et al.
JOURNAL OF PERIODONTOLOGY (2008)
Patellofemoral full-thickness chondral defects treated with hyalograft-C - A clinical, arthroscopic, and histologic review
Alberto Gobbi et al.
AMERICAN JOURNAL OF SPORTS MEDICINE (2006)
分享论文
